Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.

Verma S, Yeddula N, Soda Y, Zhu Q, Pao G, Moresco J, Diedrich JK, Hong A, Plouffe S, Moroishi T, Guan KL, Verma IM.

Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7363-7370. doi: 10.1073/pnas.1822155116. Epub 2019 Mar 27.

PMID:
30918126
2.

Targeting CREB Pathway Suppresses Small Cell Lung Cancer.

Xia Y, Zhan C, Feng M, Leblanc M, Ke E, Yeddula N, Verma IM.

Mol Cancer Res. 2018 May;16(5):825-832. doi: 10.1158/1541-7786.MCR-17-0576. Epub 2018 Mar 9.

3.

Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.

Yeddula N, Xia Y, Ke E, Beumer J, Verma IM.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6476-85. doi: 10.1073/pnas.1520110112. Epub 2015 Nov 5.

4.

Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.

Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma IM.

Nat Cell Biol. 2015 Apr;17(4):532. doi: 10.1038/ncb3145. No abstract available.

PMID:
25812528
5.

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.

Xia Y, Liu YL, Xie Y, Zhu W, Guerra F, Shen S, Yeddula N, Fischer W, Low W, Zhou X, Zhang Y, Oldfield E, Verma IM.

Sci Transl Med. 2014 Nov 19;6(263):263ra161. doi: 10.1126/scitranslmed.3010382.

6.

Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.

Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma IM.

Nat Cell Biol. 2012 Feb 12;14(3):257-65. doi: 10.1038/ncb2428. Erratum in: Nat Cell Biol. 2015 Apr;17(4):532.

Supplemental Content

Loading ...
Support Center